AM22-07-O - AM22-07-O: (On-Demand) Oral Abstract Session- Platelets and Novel Therapeutics (Enduring)

Nov 7, 2022 5:00pm ‐ Nov 7, 2022 6:00pm

Expiration Date: Dec 31, 2024

Credits: None available.

Overview
CE Information

This is an oral abstract session about Platelets and Novel Therapeutics.

Learning Objectives:

Consider an innovative therapeutic agent that could be useful for the treatment of all immune cytopenias
Discuss a potential novel therapy for IgG-mediated hemolysis
Examine the alloantibody response to platelet transfusions and platelet rich plasma

Speaker(s):

Rachael Jackman, PhD, Vitalant Research Institute
Melika Loriamini, Laboratory Medicine and Pathobiology
Johnson Tran, PhD, Vitalant Research Institute
Boya Zhang, MS, University of Michigan Pharmacology

Moderator(s):

Larry Luchsinger, PhD, New York Blood Center
Mortiz Stolla, MD, PhD, Bloodworks Northwest Research Institute

Tags:

immunotherapies includes car t cells hematology and coagulation

By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM22-07-O: (On-Demand) Oral Abstract Session- Platelets and Novel Therapeutics (Enduring) Evaluation

1.00 - General Continuing Education (GEN)
1.00 - Florida Lab Personnel (FLP)
1.00 - California Nurse (CN)
1.00 - California Lab Personnel (CLP)